References
Araki, Yasuto, Yoshimi Aizaki, Kojiro Sato, Hiromi Oda, Riki Kurokawa, and Toshihide Mimura. 2018. “Altered Gene Expression Profiles of Histone Lysine Methyltransferases and Demethylases in Rheumatoid Arthritis Synovial Fibroblasts.” Clinical and Experimental Rheumatology 36 (2): 314–16.
Bagislar, Sevgi, Arianna Sabò, Theresia R. Kress, Mirko Doni, Paola Nicoli, Stefano Campaner, and Bruno Amati. 2016. “Smyd2 Is a Myc-Regulated Gene Critical for MLL-AF9 Induced Leukemogenesis.”Oncotarget 7 (41): 66398–415. https://doi.org/10.18632/oncotarget.12012.
Boehm, Daniela, Mark Jeng, Gregory Camus, Andrea Gramatica, Roland Schwarzer, Jeffrey R. Johnson, Philip A. Hull, et al. 2017. “SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency.”Cell Host and Microbe 21 (5): 569-579.e6. https://doi.org/10.1016/j.chom.2017.04.011.
Bottino, Cinzia, Alessia Peserico, Cristiano Simone, and Giuseppina Caretti. 2020. “SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways.” Cancers 12 (1): 142. https://doi.org/10.3390/cancers12010142.
Brown, Mark A., Melissa A. Edwards, Ilham Alshiraihi, Huimin Geng, Joseph D. Dekker, and Haley O. Tucker. 2020. “The Lysine Methyltransferase SMYD2 Is Required for Normal Lymphocyte Development and Survival of Hematopoietic Leukemias.” Genes and Immunity 21 (2): 119–30. https://doi.org/10.1038/s41435-020-0094-8.
Brown, Mark A., Robert J. Sims, Paul D. Gottlieb, and Philip W. Tucker. 2006. “Identification and Characterization of Smyd2: A Split SET/MYND Domain-Containing Histone H3 Lysine 36-Specific Methyltransferase That Interacts with the Sin3 Histone Deacetylase Complex.” Molecular Cancer 5 (1): 26. https://doi.org/10.1186/1476-4598-5-26.
Du, Shao Jun, Xungang Tan, and Jianshe Zhang. 2014. “SMYD Proteins: Key Regulators in Skeletal and Cardiac Muscle Development and Function.”Anatomical Record 297 (9): 1650–62. https://doi.org/10.1002/ar.22972.
Hay, Jodie, Kathryn Gilroy, Camille Huser, Anna Kilbey, Alma Mcdonald, Amanda MacCallum, Ailsa Holroyd, Ewan Cameron, and James C. Neil. 2019. “Collaboration of MYC and RUNX2 in Lymphoma Simulates T-Cell Receptor Signaling and Attenuates P53 Pathway Activity.” Journal of Cellular Biochemistry 120 (10): 18332–45. https://doi.org/10.1002/jcb.29143.
Hwang, Inkyu, and Paul D. Gottlieb. 1995. “Bop: A New T-Cell-Restricted Gene Located Upstream of and Opposite to Mouse CD8b.”Immunogenetics 42 (5): 353–61. https://doi.org/10.1007/BF00179396.
———. 1997. “The Bop Gene Adjacent to the Mouse CD8b Gene Encodes Distinct Zinc-Finger Proteins Expressed in CTLs and in Muscle.”Journal of Immunology (Baltimore, Md. : 1950) 158 (3): 1165–11674.
Li, Quanxi, Catherine R. Lawrence, Romana A. Nowak, Jodi A. Flaws, Milan K. Bagchi, and Indrani C. Bagchi. 2018. “Bisphenol A and Phthalates Modulate Peritoneal Macrophage Function in Female Mice Involving SYMD2-H3K36 Dimethylation.” Endocrinology 159 (5): 2216–28. https://doi.org/10.1210/en.2017-03000.
Lin, Fujia, Danjuan Wu, Dan Fang, Yao Chen, Haitao Zhou, and Caiwen Ou. 2019. “STAT3-Induced SMYD3 Transcription Enhances Chronic Lymphocytic Leukemia Cell Growth in Vitro and in Vivo.” Inflammation Research 68 (9): 739–49. https://doi.org/10.1007/s00011-019-01257-5.
Lin, Yi Ching, Yu Chih Lin, Ming Yii Huang, Po Lin Kuo, Cheng Chin Wu, Min Sheng Lee, Chong Chao Hsieh, et al. 2017. “Tumor Necrosis Factor-Alpha Inhibitors Suppress CCL2 Chemokine in Monocytes via Epigenetic Modification.” Molecular Immunology 83: 82–91. https://doi.org/10.1016/j.molimm.2017.01.009.
Liu, Cheng, Dawei Xu, Hongya Han, Yidong Fan, Frida Schain, Zhonghua Xu, Hans Erik Claesson, Magnus Björkholm, and Jan Sjöberg. 2012. “Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/Demethylation.” PLoS ONE 7 (12): 1–9. https://doi.org/10.1371/journal.pone.0052703.
Ma, Wei, Yingying Zhang, Yu Qi, and Shidong Guo. 2019. “STAT3 Promotes Chronic Lymphocytic Leukemia Progression through Upregulating SMYD3 Expression.” Archives of Medical Science 15 (5): 1163–75. https://doi.org/10.5114/aoms.2018.77733.
Mossel, Dieuwertje M., Kondaiah Moganti, Vladimir Riabov, Christel Weiss, Stefan Kopf, Julio Cordero, Gergana Dobreva, et al. 2020. “Epigenetic Regulation of S100A9 and S100A12 Expression in Monocyte-Macrophage System in Hyperglycemic Conditions.”Frontiers in Immunology 11 (June): 1–19. https://doi.org/10.3389/fimmu.2020.01071.
Nagata, D. E.De Almeida, H. A. Ting, K. A. Cavassani, M. A. Schaller, S. Mukherjee, C. Ptaschinski, S. L. Kunkel, and N. W. Lukacs. 2015. “Epigenetic Control of Foxp3 by SMYD3 H3K4 Histone Methyltransferase Controls ITreg Development and Regulates Pathogenic T-Cell Responses during Pulmonary Viral Infection.” Mucosal Immunology 8 (5): 1131–43. https://doi.org/10.1038/mi.2015.4.
Oliveira-Santos, Wilson, Doralina Amaral Rabello, Antônio Roberto Lucena-Araujo, Fábio Morato de Oliveira, Eduardo Magalhaes Rego, Fábio Pittella Silva, and Felipe Saldanha-Araujo. 2016. “Residual Expression of SMYD2 and SMYD3 Is Associated with the Acquisition of Complex Karyotype in Chronic Lymphocytic Leukemia.” Tumor Biology 37 (7): 9473–81. https://doi.org/10.1007/s13277-016-4846-z.
Parmar, Naveen, Pragya Chandrakar, and Susanta Kar. 2020. “Leishmania Donovani Subverts Host Immune Response by Epigenetic Reprogramming of Macrophage M(Lipopolysaccharides + IFN-γ)/M(IL-10) Polarization.”The Journal of Immunology 204 (10): 2762–78. https://doi.org/10.4049/jimmunol.1900251.
Peveling-Oberhag, Jan, Franziska Wolters, Claudia Döring, Dirk Walter, Ludger Sellmann, René Scholtysik, Marco Lucioni, et al. 2015. “Whole Exome Sequencing of Microdissected Splenic Marginal Zone Lymphoma: A Study to Discover Novel Tumor-Specific Mutations.” BMC Cancer 15 (1): 1–10. https://doi.org/10.1186/s12885-015-1766-z.
Rasmussen, Tara, and Haley Tucker. 2018. “Loss of SMYD1 Results in Perinatal Lethality via Selective Defects within Myotonic Muscle Descendants.” Diseases 7 (1): 1. https://doi.org/10.3390/diseases7010001.
Sakamoto, Luis Henrique Toshihiro, Rosangela Vieira de Andrade, Maria Sueli Soares Felipe, Andrea Barretto Motoyama, and Fabio Pittella Silva. 2014. “SMYD2 Is Highly Expressed in Pediatric Acute Lymphoblastic Leukemia and Constitutes a Bad Prognostic Factor.” Leukemia Research 38 (4): 496–502. https://doi.org/10.1016/j.leukres.2014.01.013.
Spellmon, Nicholas, Joshua Holcomb, Laura Trescott, Nualpun Sirinupong, Zhe Yang, Nicholas Spellmon, Joshua Holcomb, Laura Trescott, Nualpun Sirinupong, and Zhe Yang. 2015. “Structure and Function of SET and MYND Domain-Containing Proteins.” International Journal of Molecular Sciences 16 (1): 1406–28. https://doi.org/10.3390/ijms16011406.
Stender, Joshua D, Gabriel Pascual, Wen Liu, Minna U Kaikkonen, Kevin Do, Nathanael J Spann, Michael Boutros, Norbert Perrimon, Michael G Rosenfeld, and Christopher K Glass. 2012. “Control of Proinflammatory Gene Programs by Regulated Trimethylation and Demethylation of Histone H4K20.” Molecular Cell 48 (1): 28–38. https://doi.org/10.1016/j.molcel.2012.07.020.
Velinder, Matthew, Jason Singer, Diana Bareyan, Jessica Meznarich, Christopher M. Tracy, James M. Fulcher, David McClellan, et al. 2016. “GFI1 Functions in Transcriptional Control and Cell Fate Determination Require SNAG Domain Methylation to Recruit LSD1.” Biochemical Journal 473 (19): 3355–69. https://doi.org/10.1042/BCJ20160558.
Vougiouklakis, Theodore, Riyue Bao, Yusuke Nakamura, and Vassiliki Saloura. 2017. “Protein Methyltransferases and Demethylases Dictate CD8+ T-Cell Exclusion in Squamous Cell Carcinoma of the Head and Neck.”Oncotarget 8 (68): 112797–808. https://doi.org/10.18632/oncotarget.22627.
Wang, Hui, Zhixin Chai, Dan Hu, Qiumei Ji, Jinwei Xin, Chengfu Zhang, and Jincheng Zhong. 2019. “A Global Analysis of CNVs in Diverse Yak Populations Using Whole-Genome Resequencing.” BMC Genomics 20 (1): 1–12. https://doi.org/10.1186/s12864-019-5451-5.
Wang, Zhixiang, Yuan Liu, Yong Xue, Haiyan Hu, Jieyu Ye, Xiaodong Li, Zhigang Lu, Fanyi Meng, and Shuang Liang. 2016. “Berberine Acts as a Putative Epigenetic Modulator by Affecting the Histone Code.”Toxicology in Vitro 36: 10–17. https://doi.org/10.1016/j.tiv.2016.06.004.
Wu, Dandan, Yang Chen, Qiming Chen, Guoming Wang, Xiaofeng Xu, A. Peng, Jin Hao, Jinguang He, Li Huang, and Jiewen Dai. 2019. “Clinical Presentation and Genetic Profiles of Chinese Patients with Velocardiofacial Syndrome in a Large Referral Centre.” Journal of Genetics 98 (2). https://doi.org/10.1007/s12041-019-1090-5.
Xu, Guiliang, Guilin Liu, Sidong Xiong, Haiyan Liu, Xi Chen, and Biao Zheng. 2015. “The Histone Methyltransferase Smyd2 Is a Negative Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6) and Tumor Necrosis Factor α (Tnf-α).” Journal of Biological Chemistry 290 (9): 5414–23. https://doi.org/10.1074/jbc.M114.610345.
Yahalom, Vered, Nir Pillar, Yingying Zhao, Shirley Modan, Mingyan Fang, Lydia Yosephi, Orna Asher, et al. 2018. “SMYD1 Is the Underlying Gene for the AnWj-Negative Blood Group Phenotype.” European Journal of Haematology 101 (4): 496–501. https://doi.org/10.1111/ejh.13133.
Yamamoto, Keiyu, Takaomi Ishida, Kazumi Nakano, Makoto Yamagishi, Tadanori Yamochi, Yuetsu Tanaka, Yoichi Furukawa, Yusuke Nakamura, and Toshiki Watanabe. 2011. “SMYD3 Interacts with HTLV-1 Tax and Regulates Subcellular Localization of Tax.” Cancer Science 102 (1): 260–66. https://doi.org/10.1111/j.1349-7006.2010.01752.x.
Yi, Xin, Xue Jun Jiang, and Ze Min Fang. 2019. “Histone Methyltransferase SMYD2: Ubiquitous Regulator of Disease.”Clinical Epigenetics 11 (1): 112. https://doi.org/10.1186/s13148-019-0711-4.
Yildirim-Buharalioğlu, Gökçe, Mark Bond, Graciela B. Sala-Newby, Charles C.T. Hindmarch, and Andrew C. Newby. 2017. “Regulation of Epigenetic Modifiers, Including KDM6B, by Interferon-γ and Interleukin-4 in Human Macrophages.” Frontiers in Immunology 8 (FEB): 1–18. https://doi.org/10.3389/fimmu.2017.00092.
Zhang, Ping, Jin Fei Ruan, Wenwen Weng, and Yongmin Tang. 2020. “Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Poor Prognosis in Pediatric B Lineage Acute Lymphoblastic Leukemia.” Leukemia and Lymphoma 61 (2): 437–44. https://doi.org/10.1080/10428194.2019.1675875.
Zhao, Fei, Yan Chen, Linglan Zeng, Rui Li, Rong Zeng, Lu Wen, Yuan Liu, and Chun Zhang. 2010. “Role of Triptolide in Cell Proliferation, Cell Cycle Arrest, Apoptosis and Histone Methylation in Multiple Myeloma U266 Cells.” European Journal of Pharmacology 646 (1–3): 1–11. https://doi.org/10.1016/j.ejphar.2010.05.034.
Zipin-Roitman, Adi, Nasma Aqaqe, Muhammad Yassin, Shahar Biechonski, Mariam Amar, Mark F. van Delft, Olga I. Gan, et al. 2017. “SMYD2 Lysine Methyltransferase Regulates Leukemia Cell Growth and Regeneration after Genotoxic Stress.” Oncotarget 8 (10): 16712–27. https://doi.org/10.18632/oncotarget.15147.
Zou, Jia Ning, Shu Zhen Wang, Jia Sen Yang, Xue Gang Luo, Jing Hang Xie, and Tao Xi. 2009. “Knockdown of SMYD3 by RNA Interference Down-Regulates c-Met Expression and Inhibits Cells Migration and Invasion Induced by HGF.” Cancer Letters 280 (1): 78–85. https://doi.org/10.1016/j.canlet.2009.02.015.